Archives for September 5, 2004

← 2004

Safety syringe packer launched by Marchesini

Italy's Marchesini has introduced a new packaging system that can handle safety syringes, which are underused in Europe compared to the US despite their proven benefits in reducing needlestick injuries, reports Phil Taylor. It has been developed by...

Genetix launch hybrid bed option for HT Microarrayer

UK Life Sciences Company Genetix has launched a new hybrid bed option designed to compliment its high-throughput, fully featured QArray microarrayer platform used to detect low-level expression of genes making it ideal for all microarray applications

Enanta initiates Phase 1 trial on BBK antibiotic for RTI

Enanta Pharmaceuticals has announced the initiation of Phase 1 clinical trial of its new antibiotic candidate, EP-013420, a first in its class Bridged Bicyclic Ketolide (BBK) antibiotic that could prove effective against respiratory pathogens,...

GSK face more legal action over antidepressant drug

GlaxoSmithKline (GSK) is facing a number of US lawsuits, which claims the company had covered up negative data that indicated its antidepressant Paxil might increase suicidal tendencies in young people.

Pfizer gets tough with Lipitor fakers

The number one drugmaker - Pfizer - has stepped up its legal campaign against the trade in counterfeit versions of its top-selling drug Lipitor (atorvastatin), one of the most copied drugs on the market.

Green solution to electronic waste

As of next year, electronics manufacturers in Europe will be required to take back and partially recycle old equipment. Beginning in 2006, electronics must be completely lead-free. An industry conference starting in Berlin, Germany today sheds light...

Unichem's US plans take shape

Unichem Laboratories of India, a major supplier of active pharmaceutical ingredients (APIs) and finished pharmaceuticals in the country, has entered into an alliance that could see it supplying generics into the US market.

Expansion plans at Cardinal Health

Cardinal Health says it plans to expand and restructure several of its facilities around the world after what it describes as 'heightened customer demand for clinical supply services, such as design, packaging, labelling, storage and distribution'.

Non-compliance costs drug industry dear

The cumulative effect of patients failing to adhere to their treatment regimens is costing the pharmaceutical industry in excess of $30 billion a year, says a new report from Datamonitor which proffers some solutions to the problem.

Guava launch new PCA system

Researchers studying cell migration and the screening of drug compounds, can benefit from a new cell analysis system developed by Guava Technologies which places an emphasis on cell health profiling that is essential in the field of drug R&D.